Perform Another (Advanced) Search

1. Clinical Trial Results by Drug Names
...Evaluating the Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS) Combined With Placebo or Lamivudine Versus Lamivudine in HBeAg-Positive Patients With Chronic Hepatitis B Fast Facts: Protocol number: WV16240 Sponsor: F ...
View Page

2. Clinical Trial Results by Drug Names
...Evaluating the Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS) Combined With Placebo or Lamivudine Versus Lamivudine in HBeAg-Negative Patients With Chronic Hepatitis B (CHB) Fast Facts: Protocol number: WV16241 Sponsor ...
View Page

3.  Newly Approved Drug Therapies (655) Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet, GlaxoSmithKline,
...Newly Approved Drug Therapies (655) Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet, GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet Company: GlaxoSmithKline Approval Status: Approved November 2000 Treatment Area: HIV Infection General ...
View Page

4.  Newly Approved Drug Therapies (537) Epivir (lamivudine), GlaxoSmithKline,
...Newly Approved Drug Therapies (537) Epivir (lamivudine), GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Epivir (lamivudine) Company: GlaxoSmithKline Approval Status: Approved April 1999 Treatment Area: Immunology/Infectious Diseases General Information 3TC ...
View Page

5.  Newly Approved Drug Therapies (25) Epivir (lamivudine), GlaxoSmithKline,
...Newly Approved Drug Therapies (25) Epivir (lamivudine), GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Epivir (lamivudine) Company: GlaxoSmithKline Approval Status: Approved on November 17, 1995 Treatment Area: AIDS/HIV infection General ...
View Page

6.  Study Posting (4519) Trial #157418, Hepatitis B, Hong Kong, Hong Kong
...Hong Kong Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

7.  Study Posting (4519) Trial #122848, Hepatitis B, Shanghai, China
...Shanghai, China Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

8.  Study Posting (4519) Trial #125769, Hepatitis B, Jinan, China
...Jinan, China Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

9.  Study Posting (4519) Trial #122844, Hepatitis B, Hangzhou, China
...Hangzhou, China Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

10.  Study Posting (4519) Trial #123506, Hepatitis B, Guangzhou, China
...Guangzhou, China Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

11.  Study Posting (4519) Trial #125520, Hepatitis B, Chongqing, China
...Chongqing, China Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

12.  Study Posting (4519) Trial #122834, Hepatitis B, Beijing, China
...Beijing, China Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV). Status: Completed Protocol Number: ML18376 Sponsor: Shanghai Roche ...
...peginterferon alfa-2a (40KD) PEGASYS® or adefovir dipivoxil (ADV) on HBeAg seroconversion in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B Brief Summary: This study will evaluate the efficacy and ...
View Page

13. Clinical Trial Results: Hepatitis B, Chronic
...Evaluating the Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS) Combined With Placebo or Lamivudine Versus Lamivudine in HBeAg-Negative Patients With Chronic Hepatitis B (CHB) Product Name: PEGASYS [peginterferon alfa-2a ...
View Page

14. Clinical Trial Results by Drug Names
...potential drug interactions between ribavirin and two nucleoside reverse transcriptase inhibitor (NRTI) regimens (zidovudine plus lamivudine and stavudine plus lamivudine) administered concomitantly with ribavirin or placebo in combination with PEGASYS (peginterferon alfa-2a (40KD)). Patients ...
View Page

15.  Study Posting (4519) Trial #147411, Hepatitis B, Villejuif, France
...the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS (180 micrograms sc ...
View Page

16.  Study Posting (4519) Trial #147409, Hepatitis B, Toulouse, France
...the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS (180 micrograms sc ...
View Page

17.  Study Posting (4519) Trial #125793, Hepatitis B, Saint Laurent Du Var, France
...the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS (180 micrograms sc ...
View Page

18.  Study Posting (4519) Trial #147854, Hepatitis B, Pessac, France
...the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS (180 micrograms sc ...
View Page

19.  Study Posting (4519) Trial #123013, Hepatitis B, Paris, France
...the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS (180 micrograms sc ...
View Page

20.  Study Posting (4519) Trial #124064, Hepatitis B, Orleans, France
...the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS (180 micrograms sc ...
View Page